PP
IDXX icon

Paloma Partners’s Idexx Laboratories IDXX Stock Holding History

Paloma Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,700
Closed -$2.37M – 647
2024
Q3 		$2.37M Sell
4,700
-5,500
-54% -$2.67M 0.07% 248
2024
Q2 		$4.97M Buy
+10,200
New +$5.12M 0.14% 126
2023
Q3 		– Sell
-1,800
Closed -$904K – 807
2023
Q2 		$904K Buy
1,800
+100
+6% +$47.9K 0.03% 382
2023
Q1 		$850K Buy
+1,700
New +$814K 0.03% 398
2022
Q4 		– Sell
-5,000
Closed -$1.63M – 1031
2022
Q3 		$1.63M Buy
5,000
+1,100
+28% +$404K 0.07% 223
2022
Q2 		$1.37M Buy
3,900
+1,700
+77% +$693K 0.05% 351
2022
Q1 		$1.2M Buy
2,200
+600
+38% +$316K 0.04% 377
2021
Q4 		$1.05M Buy
+1,600
New +$1M 0.02% 695
2017
Q4 		– Sell
-13,300
Closed -$2.07M – 2072
2017
Q3 		$2.07M Buy
+13,300
New +$2.1M 0.03% 718

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paloma Partners's IDXX Position: Q2 2025 in Review

Paloma Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 659 shares — an estimated $277K sold.

Paloma Partners first reported a position in IDXX in Q2 2013 and held it in 25 quarters. The position peaked at $5.1M in Q3 2015. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Paloma Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 659 Idexx Laboratories shares in Q2 2025, an estimated $277K.
  • Paloma Partners first reported a position in Idexx Laboratories in Q2 2013 and held it in 25 quarters.
  • Paloma Partners's Idexx Laboratories position peaked at $5.1M in Q3 2015.
  • 1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.